Mapping the Knowledge on Coping Processes in Patients with Pancreatic Cancer by Ristau, Patrick et al.
 
 




Mapping the Knowledge on Coping Processes in Patients 
with Pancreatic Cancer: A Scoping Review Protocol 
 
 
Patrick Ristau1*, Claudia Oetting-Roß2, Andreas Büscher1,3 
 
1Witten/Herdecke University, Faculty of Health, School of Nursing Science, Alfred-Herrhausen-
Straße 50, 58455 Witten, Germany  
2FH Münster, University of Applied Sciences, Münster School of Health, Leonardo-Campus 8, 48149 
Münster, Germany 
3Osnabrück University of Applied Sciences, Faculty of Business Management and Social Sciences, 





Background: Pancreatic cancer is one of the malignant diseases with the highest cancer-
specific mortality. At the time of diagnosis, life expectancy is often already very limited, as it 
is usually discovered late and in an advanced stage. Coping with cancer is a complex process. 
Coping strategies of patients with pancreatic cancer probably differ from those of other 
malignancies. Yet to date, there exists no pancreatic cancer-specific coping model. 
 
Objective: The objective of this scoping review is to explore and characterize the academic 
literature related to coping processes in patients with pancreatic cancer. 
 
Methods/Design: The JBI's three-step search strategy, combined with the Arksey and 
O'Malley framework, will be used to identify articles via PubMed/MEDLINE, CINAHL, 
Cochrane Library, Google Scholar, CAMbase, CareLit, CC Med, Scopus, and 
PsycARTICLES (Arksey & O'Malley, 2005; Peters et al., 2017). It follows the PRISMA 
guidelines for scoping reviews (Tricco et al., 2018). Primary and secondary studies and 
reviews which report on coping with pancreatic cancer (adenocarcinoma) in adults in English 
or German language will be included in this scoping review, regardless of publication date or 
study design. 
 
Discussion: This scoping review will add new insights on coping with pancreatic cancer by 
summarizing current knowledge, and identifying research gaps. Findings may be used as a 
foundation for future research. 
 
Systematic review registration: Open Science Framework (https://osf.io/ug3sf). 
 
Keywords: Pancreatic cancer, Pancreatic adenocarcinoma, Coping, Adaptation, Cancer 
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1.  Background 
Pancreatic adenocarcinoma, which causes 95% of pancreatic cancer cases, is among the 
malignancies with the highest cancer-specific mortality (Oettle et al., 2018). This disease has 
an overall five-year survival rate of only approximately 10% in Germany (Robert Koch-
Institut & Gesellschaft der epidemiologischen Krebsregister in Deutschland e.V., 2017). In 
only approximately 15–20% of cases, a potentially curative therapy (R0 resection) with a 
five-year survival rate of approximately 20% may be considered (Ducreux et al., 2015). The 
median survival time in advanced stages depends on the extent to which the tumour has 
grown and spread; regarding locally advanced cancer, the average survival time is less than 
one year (Huang et al., 2018), but new treatment regimens may extend the time to 
approximately two years (Suker et al., 2016). Regarding metastatic pancreatic tumours, the 
most prevalent stage at diagnosis, the average survival time is less than six months (Huang et 
al., 2018). Patient and institutional factors may influence care delivery and outcomes 
(Gagliardi et al., 2016). 
Pancreatic cancer – like many other tumour diseases - suddenly and unexpectedly plunges 
those affected into a fundamental life crisis. A cancer diagnosis is an enormous emotional 
shock and is equivalent to a catastrophe, or a "disruptive event" (Bury, 1982), as the 
diagnosis impacts different dimensions of patients’ lives, including psychological, social, 
physical, and spiritual dimensions (MacDonald, 2001). Patients never forget the day of their 
diagnosis (Federspiel & Schiffner-Backhaus, 1999). 
To	 understand the processes that patients go through when confronted with a serious 
illness and to make these processes comprehensible and tangible to outsiders, several 
adaptation models have been developed in recent years in various disciplines. Frequently 
applied approaches include the adaptation model proposed by Roy (Roy & Roberts, 1981), 
the trajectory model developed by Corbin and Strauss	(Corbin & Strauss, 1991), the illness 
constellation model of Morse and Johnson (Morse, 1991), and the shifting perspectives model 
created by Paterson (Paterson, 2001). 
Since the mid-1980s, research on disease behaviour has shifted to research on coping 
behaviour. Lazarus and Folkman (Lazarus & Folkman, 1984) provided probably the best 
known definition of coping with disease. According to their definition, coping is "constantly 
changing cognitive and behavioural efforts to manage specific external and/or internal 
demands that are appraised as taxing or exceeding the resources of the person” (Lazarus & 
Folkman, 1984, p. 141). This definition largely encompasses what is now subsumed under 
the term “coping” (Schüßler, 2000). Coping is a complex process and is determined by 
various socio-cultural, psychological and medical variables (Barroilhet Díez et al., 2005). 
Since the proposal of Lazarus and Folkman’s definition, dealing with a disease has been 
linked to a success criterion: patients dealing with their disease as successfully as possible to 
cope with it. Furthermore, it can be stated that coping models attempt to categorise patients 
into two groups: those with successful coping processes and those without them. In summary, 
one could also distinguish "good" from "bad" coping. However, this approach unnecessarily 
prevents a close look at the various ways of dealing with one's own illness (Franke, 2012). 
Nevertheless, coping with illness is currently usually seen as a transactional process: The 
perception of, evaluation of and response to a disease have an effect on the state of the 
disease, its perception and coping,	 and coping with a disease is considered to be 
multidimensional and characterized by various conditions (Schüßler, 2000). 
As Halldorsdottir and Hamrin stated, it is important that health professionals develop a 
better sense of what it means to go through existential human experiences from a patient’s 
perspective. This sense might enable health professionals to better handle being confronted 
 
 




with patients’ pain, shame or existential experiences (Halldorsdottir & Hamrin, 1996). 
Therefore, a study describing the cancer experience from the patient perspective should serve 
to increase awareness and understanding of this experience among health professionals 
(MacDonald, 2001). 
Although the coping strategies of cancer patients have been studied (Carver, 2005; Stanton 
et al., 2005) and some disease-specific models, e.g., models for lung or breast cancer, exist 
(Mehrabi et al., 2015; Mosher et al., 2015), limited research has focused on pancreatic cancer 
patients. A corresponding model for coping with pancreatic cancer is still lacking, although 
there is already much evidence on some influencing variables and procedures (e.g. on 
pancreatectomy, see Lounis et al., 2019; Scholten et al., 2019). This is particularly 
noteworthy, as the currently available theories and models cannot simply be applied to 
pancreatic cancer. 
It is quite possible that the coping strategies of pancreatic cancer patients differ from those 
of other cancer patients, as pancreatic cancer patients are usually confronted with the fast 
progress of their disease due to late detection at an advanced stage and intensive medical 
treatments (McGuigan et al., 2018). In many cases, pancreatic cancer patients must deal with 
major changes in their health status within a short time before, during and, in some cases, 
after treatment, which often have a restrictive effect on their living conditions (e.g. Herman et 
al., 2019). 
It should	be noted that those affected have many informational and supportive care needs 
regarding symptom management and communication with health care providers. They worry 
about loved ones and the uncertainty of the future (Beesley et al., 2016). 
As Jia et al. stated, cancer-related depression is a frequent psychological disorder in people 
suffering from pancreatic cancer. Its incidence is significantly higher among pancreatic 
patients (78.0%) than	among	patients	with other gastrointestinal malignancies, such as liver 
cancer (60.0%), gastric cancer (36.0%) or colorectal cancer (19.2%). Additionally, depression 
significantly lowers the Quality of Life (QoL) of pancreatic cancer patients (Jia et al., 2010). 
The quality of life of people with pancreatic cancer is also worse compared to patients with 
other types of cancer (Bauer et al., 2018). 
Patients must adjust to and deal with these challenges, but it is unclear whether and in 
what ways coping processes are possible due to the often limited life expectancy associated 
with this type of cancer. It can be assumed that in many cases, patients have no or only very 
short stable phases due to the	abovementioned short survival times. Furthermore, only a	few 
people with pancreatic cancer enter a chronic phase, while there are increasing numbers of 
survivors of other types of cancer (Miller et al., 2019; Parry et al., 2011; Phillips & Currow, 
2010). 
In a recent meta-review published in 2019, Laidsaar-Powell et al. analysed current 
strengths and evidence gaps in qualitative research on adult cancer survivors (2019). They 
found that breast and gynaecological cancer survivors are strongly represented in current 
research. Gaps in evidence synthesis include reviews for other common cancers (e.g., lung, 
colorectal and melanoma, and haematological) as well as survivorship topic areas. In 
particular, Laidsaar-Powell et al. identified no systematic reviews of the survival of people 
with pancreatic cancer published between 1950 and 2018. To	use the experiences of cancer 
survivors as a basis for guiding the development of interventions and giving others insight 
into the experiences and challenges of cancer patients, more research is needed. 
In August 2020, an exploratory scan of previously published reviews on coping processes 
in patients with pancreatic cancer in PubMed, CINAHL and Cochrane Libraries yielded no 
results. The search strategy applied is shown below in Table 1. 
 
 




Table 1.  Exploratory scan on previously published (scoping) reviews on coping processes in  









OR	 ("pancreatic	 neoplasm*"))	 OR	
("pancreatic	 malignanc*"))	 OR	 ("pancreatic	
adenocarcinoma"))	 OR	 ("pancreatic	
tumor*"))	 OR	 ("pancreatic	 tumour*"))	 OR	
("pancreatic	 carcinoma"))	 OR	 ("pancreatic	
cancer"))	 AND	 ((((behavior,	 coping[MeSH	







CINAHL	 (((pancreatic	 neoplasm*)	 OR	 (pancreatic	
malignanc*)OR	(pancreatic	adenocarcinoma)	
OR	 (pancreatic	 tumor*)	 OR	 (pancreatic	
tumour*)	 OR	 (pancreatic	 carcinoma)	 OR	
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(MeSH	 descriptor:	 [Carcinoma,	 Pancreatic	
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As a result, conduction of a scoping review seems appropriate to summarise knowledge on 
the coping processes in people with pancreatic cancer, as it can be used to map the key 
concepts that underpin a field of research (Arksey & O'Malley, 2005). Therefore, the 
following research question is intended to answer: 
What is currently known about coping processes in patients with pancreatic cancer?  
The scoping review outlined in this paper aims to explore the knowledge on coping processes 
in patients with pancreatic cancer. The methodological approach, objectives, search 
strategies, selection processes, and reporting are described in the following sections. 
 
2.  Methods/Design 
2.1  Protocol design 
This scoping review protocol was prospectively registered in the Open Science 
Framework to guarantee good scientific practice and transparency regarding both the research 
process and the future findings. The protocol can be found there at https://osf.io/ug3sf. It is 
reported in accordance with the reporting guidelines outlined in the Preferred Reporting Items 
 
 




for Systematic Review and Meta-Analysis Protocols (PRISMA-P) (Moher et al., 2015) 
statement and the PRISMA Extension for Scoping Reviews (PRISMA-ScR) (Tricco et al., 
2018). This study does not require ethical approval, as the scoping review methodology is 
based on the collection and review of data from publicly available sources instead of the 
collection of new data from humans. 
The scoping review will review the existing literature on coping with pancreatic cancer. It 
will be guided by the methodological framework outlined by Arksey and O’Malley (Arksey 
& O'Malley, 2005). This framework defines the following six stages to be considered when 
developing a scoping review: 
1. Identifying the research question, 
2. Identifying relevant studies, 
3. Selecting the studies, 
4. Charting the data, and 
5. Collating, summarising, and reporting the results. 
Stages 2, 3 and 4 proceed as an iterative process. Throughout the entire process of the 
scoping review, it may be necessary and useful to seek optional expert consultation or 
consultation with relevant stakeholders. The process of the scoping review is shown in Figure 
2 based on the framework of Arksey and O'Malley (Arksey & O'Malley, 2005).  
 





The stages and how they will be applied in the proposed scoping review are discussed 
below. 
 
Stage 1. Identifying the research question: 
Based on an initial scan of the existing literature and the presentation of results in the 
background section, the following research question was developed: What is currently known 
about coping processes in patients with pancreatic cancer?  
 
 




This question will be answered through the scoping review outlined in this paper. The aim 
of the scoping review is to summarise knowledge on the coping processes in people with 
pancreatic cancer and to disseminate research findings in medicine and health sciences 
through scientific publications and presentations. Gaps in the current research literature on 
coping with pancreatic cancer will also be identified. The results will be used as a foundation 
for developing methodological ideas and theoretical approaches to future research studies on 
coping with pancreatic cancer (Arksey & O'Malley, 2005; Coughlan & Cronin, 2017; Peters 
et al., 2017). 
 
Stage 2. Identifying relevant studies: 
The three-step search strategy recommended by the Joanna Briggs Institute (JBI) will be 
applied in this scoping review (Peters et al., 2017). This strategy is illustrated in Figure 3. 
 




As a first step, the PubMed, CINAHL, and Cochrane Library databases will be searched. 
Titles, abstracts, and index terms of the hits retrieved will be analysed regarding possible 
search terms.  
As a second step, all databases (PubMed, CINAHL, and Cochrane Library, Google 
Scholar, CAMbase, CareLit, CC Med, Scopus, and PsycARTICLES) will be scanned with 
the keywords and index terms identified. These scientific databases were chosen for their 
relevance to specific professions, because they reflect the multidisciplinary nature of the 
phenomenon of interest, and because they are freely accessible or can often be accessed by 
researchers through their universities. No date limits will be imposed on the search strategy. 
Boolean terms, such as “AND”, “OR” and “NOT”, will be used to separate and combine 
keywords when applicable. An example search strategy for PubMed and results of a pilot 
search run carried out on August 15, 2020 are illustrated in Table 2. Optional consultation by 
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#13	 ((((((("pancreatic	 neoplasm*")	 OR	
("pancreatic	 adenocarcinoma"))	 OR	
("pancreatic	 tumor*"))	 OR	 ("pancreatic	
tumour*"))	 OR	 ("pancreatic	
neoplasms"[MeSH	 Terms]))	 OR	
("pancreatic	 carcinoma"))	 OR	 ("pancreatic	
cancer"))	 AND	 (((((behavior,	 coping[MeSH	







As the third and last step of this stage, the reference lists of the included studies will be 
browsed for potential additional studies. The search will be limited to the reference lists of 
those articles that have been included in the scoping review. 
The Population, Concept, Context (PCC) framework, which is recommended by the JBI, 












Table 3.  PCC framework based on recommendations by JBI (Peters et al., 2017). 
 
PCC	ELEMENT	 DEFINITION	
P	–	POPULATION	 Adults	 with	 pancreatic	 cancer	
(adenocarcinoma)	 at	 any	
stages	 and	 with	 any	
therapeutic	goals		
C	–	CONCEPT	 Coping	with	pancreatic	cancer	
C	–	CONTEXT	 Including	 all	 study	 designs	 on	
coping	 with	 pancreatic	 cancer	
in	English	or	German	language,	
no	 restrictions	 on	 setting	 or	
date	or	study	design	
 
Stage 2 inclusion and exclusion criteria: 
To be included in the scoping review, papers will need to report on people coping with 
pancreatic cancer. As approximately 95% of the cases of pancreatic cancer are pancreatic 
adenocarcinoma (Oettle et al., 2018), it can be assumed that the articles will also refer to this 
type of cancer unless clearly stated otherwise. Journal papers will be included if they are 
written in English or German language. Papers on quantitative, qualitative and mixed-method 
studies will be included as well as those on primary or secondary studies and reviews	 to 
include all available knowledge on the research topic knowledge (e.g., coping with therapy 
effects within the context of drug approval and side effect studies and spirituality and faith 
within the context of qualitative studies). 
Papers will be excluded if they do not align with the conceptual framework or if they 
focus on another (pancreatic) disease. Furthermore, studies that clearly focus on tumour 
entities other	 than pancreatic adenocarcinoma will be excluded. In addition, letters, 
comments, opinions, discussion papers, websites, etc., that have not been published in 
journals as well as studies that do not have an abstract available will not be considered. 
There will be no limitations on the timeframe or study design and no restrictions regarding 
therapy goals or strategies. 
In	addition	to the inclusion criteria, the exclusion criteria are listed in Table 4 below. 
 
Table 4.  Inclusion and exclusion criteria. 
 
	 INCLUSION	CRITERIA	 EXCLUSION	CRITERIA	
POPULATION	 Adults	 living	 with	 pancreatic	
carcinoma	
People	 with	 all	 other	 types	 of	 (pancreatic)	
diseases	
LANGUAGE	 English	or	German	 All	other	languages	
TYPE	OF	ARTICLE	 Primary	 and	 secondary	
studies	and	reviews	
Unpublished	 studies	 or	 studies	 with	 no	 abstract	
available,	 commentaries	 or	 opinions,	 letters,	
discussion	papers,	websites	
STUDY	FOCUS	 Studies	 that	 report	 on	 the	












Eligible articles will be imported into Citavi 6 for Windows 10. This software will allow 
the identification and removal of duplicates through the comparison of titles and, if 
necessary, abstracts. The software will also be used for managing records, keeping track of 
articles, and producing a list of references to be included in the final review report. 
 
Stage 3. Selecting the studies: 
The articles will be systematically selected through a three-stage procedure. 
Stage 1: The titles and abstracts of all articles identified in the search will be stored 
electronically in Citavi 6.5 and reviewed by the first author. For this purpose, a previously 
prepared checklist will be used. To validate the selection process, at least 10% of the articles 
will be reviewed by another independent reviewer.	This process will continue until the two 
reviewers have reached a common understanding of how to apply the inclusion criteria and 
resolved any disagreement on the inclusion of publications. 
Step 2: Next, the remaining articles will be stored electronically in Citavi 6.5 in full	 text 
and evaluated in detail according to the inclusion and exclusion criteria by the first author. As 
in step 1, the checklist will be used. Furthermore, another reviewer will second-screen articles 
in the same manner as described above until all disagreements have been resolved and both 
authors have reached full agreement on the application of the inclusion criteria. 
Step 3: The first author will refer any articles about which he is uncertain regarding their 
inclusion to a supervisor for review. The research output derived from the various steps will 
be illustrated in a PRISMA flow chart (Moher et al., 2009). A draft is presented in Figure 1. 
Methodological quality will not be evaluated in accordance with the scoping review 
methodology (Peters et al., 2017). 
 










Stage 4: Charting the data: 
Key pieces of information from the abstracts of the selected articles will be collected and 
organised. Standard data items will be extracted and reported. These items will include 
bibliographical information (author, title, journal, year of publication, and language), 
objectives of the paper, target population and setting, type of study, and country/region where 
the study was conducted. A draft of the data charting form is shown in Table 4. 
 











TARGET	POPULATION	 	 E.g.,	 specific	 age	 groups,	 gender,	 therapy	
regime	
SETTING	 	 E.g.,	 inpatient/outpatient,	
palliative/curative	





To ensure that the coding framework is consistently applicable, the framework will be 
pilot tested on a sample (20%) of the included studies. Additional categories may emerge 
during this process. If so, the categories will be modified, and the data extraction framework 
will be revised. Questions arising during pilot testing will be discussed among the 
researchers, and possible disagreement will be resolved through team consultations. Missing 
data may be found in some eligible abstracts. This will be resolved and documented in 
consultation with team members. The authors of those articles will be contacted via e-mail or 
ResearchGate if possible in	an attempt to obtain the required details. If the authors contacted 
do not respond to the request within two weeks, the study in question will be noted as having 
unavailable information. Nevertheless, the study will be included in the results with an 
appropriate reference to the unavailable information. 
 
Stage 5. Collating, summarising, and reporting the results: 
The scoping review outlined in this protocol aims	to map the current knowledge of coping 
in people with pancreatic cancer. The analysis of the data collected using the data extraction 
framework will help to obtain a deeper understanding of coping processes and the challenges 
that people confront due to their illness.  
The scoping review will present a narrative report of	 the existing literature. In addition, 
core results and findings will be presented in a table according to the data extraction 
framework shown above.  
The analysis will provide information about both the existing knowledge and current 
research gaps and offer an outline of the published research rather than an assessment of the 
 
 




quality of the relevant studies. It might also provide an overview of existing interventions to 
support coping processes or possible assistance in overcoming challenges for those affected. 
 
4. Discussion 
Within this protocol, we have presented our planned scoping review, which will 
summarise the present knowledge on the coping processes of people with pancreatic cancer 
and will aim to identify current gaps in research.  
A possible limitation of our approach is that only English and German language articles 
for which an abstract is available will be included in the scoping review. 
The publication of scoping review protocols in advance increases transparency in the 
description of study methods and enhances the value of results. It also enables peer reviewers 
and other researchers to make critical comments. The authors will conduct this study as 
described here but will consider any proposed methodological refinement regarding the 
objective and purpose of the review in an appropriate manner. 
A dissemination of research findings on coping with pancreatic cancer in medicine and the 
health sciences through the submission of an article for publication to a scientific journal, 
participation in conferences and presentations will help increase awareness and empathy and 
provide better care for those affected.  
The identification of gaps in the current research literature may provide a foundation for 
developing methodological ideas and theoretical approaches for future research studies on 
coping with pancreatic cancer, and could help to improve the quality of care for patients by 
developing targeted interventions. 
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